G. Pöch

发表

Application of the isobologram technique for the analysis of combined effects with respect to additivity as well as independence.

R. Reiffenstein, G. Pöch, H. Unkelbach, 1990, Canadian journal of physiology and pharmacology.

Dose-response curves of vasorelaxants: computerized calculation of combination effects using the example of nicorandil

G. Pöch, P. Dittrich, S. Holzmann, 1999 .

Quantitative estimation of potentiation and antagonism by dose ratios corrected for slopes of dose-response curves deviating from one.

R. Reiffenstein, G. Pöch, H. Baer, 1995, Journal of pharmacological and toxicological methods.

Calculating slope and ED50 of additive dose-response curves, and application of these tabulated parameter values.

G. Pöch, S. Pancheva, 1995, Journal of pharmacological and toxicological methods.

Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.

G. Pöch, W. Kukovetz, S. Holzmann, 1992, European journal of pharmacology.

Evaluation of combined effects in dose-response studies by statistical comparison with additive and independent interactions.

G. Pöch, P. Dittrich, S. Holzmann, 1990, Journal of pharmacological methods.

Time-dependence in mixture toxicity with soft-electrophiles: 2. Effects of relative reactivity level on time-dependent toxicity and combined effects for selected Michael acceptors

Joshua L. Allen, T. Schultz, G. Pöch, 2007, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

Time Dependence in Mixture Toxicity with Soft Electrophiles: 1. Combined Effects of Selected SN2- and SNAr-Reactive Agents with a Nonpolar Narcotic

T. Schultz, G. Pöch, D. Dawson, 2007, Archives of environmental contamination and toxicology.

Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes.

M. Thiel, G. Pöch, H. Bardenheuer, 1991, Biochemical and biophysical research communications.

Inhibition of cyclic-3′,5′-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs

G. Pöch, W. Kukovetz, 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.

Molecular Mechanism of Action of Nicorandil

G. Pöch, W. Kukovetz, S. Holzmann, 1992, Journal of cardiovascular pharmacology.

Cardiostimulatory effects of cyclic 3′,5′-adenosine monophosphate and its acylated derivatives

G. Pöch, W. Kukovetz, 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.

Assay of phosphodiesterase with radioactively labeled cyclic 3′,5′-AMP as substrate

G. Pöch, 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.

Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues.

G. Pöch, W. Kukovetz, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Function of cyclic GMP in acetylcholine-induced contraction of coronary smooth muscle

G. Pöch, W. Kukovetz, S. Holzmann, 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

Eicosapentaenoic acid inhibits vasoconstrictor- and noradrenaline-potentiating effects of neuropeptide Y in the isolated rabbit ear.

A. Saria, G. Pöch, H. Juan, 1988, Journal of the autonomic nervous system.

[Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].

G. Pöch, 1981, Arzneimittel-Forschung.

Characterization of muscarinic receptors mediating endothelium-dependent relaxation of bovine coronary artery.

G. Pöch, K. Groschner, W. Kukovetz, 1991, European journal of pharmacology.

Quantitative relations between cyclic AMP and contraction as affected by stimulators of adenylate cyclase and inhibitors of phosphodiesterase.

A. Wurm, G. Pöch, W. Kukovetz, 1975, Advances in cyclic nucleotide research.

Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase

G. Pöch, Walter Umfahrer, 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.

[Pharmacological Properties of Fendiline in Cardiac and Smooth Muscle (author's transl)].

E. Paietta, G. Pöch, W. Kukovetz, 1976, Arzneimittel-Forschung.

Effect of Phosphodiesterase-Inhibition on Smooth Muscle Tone

A. Wurm, E. Paietta, G. Pöch, 1976 .

[Role of cyclic AMP in coronary circulation].

G. Pöch, W. Kukovetz, S. Holzmann, 1974, Die Medizinische Welt.

Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.

G. Pöch, W. Kukovetz, 1972, Advances in cyclic nucleotide research.

Evaluation of dose-response curve analysis in delineating shared or different molecular sites of action for osteolathyrogens.

A. Rinaldi, G. Pöch, D. Dawson, 2004, Environmental toxicology and pharmacology.

Biochemical and toxicological evaluation of agent-cofactor reactivity as a mechanism of action for osteolathyrism.

A. Rinaldi, G. Pöch, D. Dawson, 2002, Toxicology.

Apparent Independent Action of Nimodipine and Glutamate Antagonists to Protect Cultured Neurons Against Glutamate-induced Damage

J. Krieglstein, G. Pöch, K. Lippert, 1996, Neuropharmacology.

Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle

A. Wurm, G. Pöch, W. Kukovetz, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of hypoxia-induced rise in adenosine release and flow by coronary dilators.

G. Pöch, W. Kukovetz, 1971, Cardiology.

Comparison of independence and additivity in drug combinations

G. Pöch, G. Pöch, H. Unkelbach, 1988 .

Evaluation of consistency for multiple experiments of a single combination in the time-dependence mixture toxicity assay

G. Pöch, D. Dawson, 2017, Toxicology mechanisms and methods.

The positive inotropic effect of cyclic AMP.

G. Pöch, W. Kukovetz, 1972, Advances in cyclic nucleotide research.

Effect of catecholamines, histamine and oxyfedrine on isotonic contraction and cyclic AMP in the guinea-pig heart

A. Wurm, G. Pöch, W. Kukovetz, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Relationship between metabolic and mechanic adrenergic stimulation of the heart under conditions of small dosage, low calcium, hypothermia and ouabain.

G. Pöch, W. Kukovetz, 1967, Biochemical pharmacology.

Prostacyclin increases cAMP in coronary arteries.

A. Wurm, G. Pöch, W. Kukovetz, 1979, Journal of cyclic nucleotide research.

Dual Mechanism of the Relaxing Effect of Nicorandil by Stimulation of Cyclic GMP Formation and by Hyperpolarization

G. Pöch, W. Kukovetz, S. Holzmann, 1991, Journal of cardiovascular pharmacology.

Comparative evaluation of the combined osteolathyritic effects of two nitrile combinations on xenopus embryos.

G. Pöch, D. Dawson, M. Cotter, 2000, Toxicology.

Role of cyclic nucleotides in adenosine-mediated regulation of coronary flow.

A. Wurm, G. Pöch, W. Kukovetz, 1978, Advances in cyclic nucleotide research.

Uniform characterization of potentiation in simple and complex situations when agents bind to different molecular sites.

R. Reiffenstein, G. Pöch, S. Pancheva, 1995, Canadian journal of physiology and pharmacology.

Evaluation of experimental combined toxicity by use of dose-frequency curves: comparison with theoretical additivity as well as independence.

A. Schuster, R. Reiffenstein, G. Pöch, 1990, Canadian journal of physiology and pharmacology.

Specific inhibition by burimamide of histamine effects on myocardial contraction and cyclic AMP

N. Scholz, G. Pöch, W. Kukovetz, 1973, Naunyn-Schmiedeberg's Archives of Pharmacology.

Potentation of the cardiac response to aminophylline by oxyfedrine

G. Pöch, W. Kukovetz, K. Sakai, 1975, Naunyn-Schmiedeberg's Archives of Pharmacology.

Drug-induced release and pharmacodynamic effects of histamine in the guinea-pig heart.

G. Pöch, W. Kukovetz, 1967, The Journal of pharmacology and experimental therapeutics.

Synergism/potentiation and antagonism — phenomena and mechanisms

G. Pöch, 1993 .

Overadditive synergism between theophylline, diprophylline and proxyphylline in tracheal smooth muscle relaxation.

G. Pöch, W. Kukovetz, S. Holzmann, 1983, Arzneimittel-Forschung.

Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.

G. Pöch, S. Holzmann, 1980, Journal of pharmacological methods.

Mixture Toxicity of SN2-Reactive Soft Electrophiles: 2—Evaluation of Mixtures Containing Ethyl α-Halogenated Acetates

T. Schultz, G. Pöch, D. Dawson, 2011, Archives of environmental contamination and toxicology.

The underlying bases of pharmacological results in agreement or disagreement with the law of initial value.

G. Pöch, F. Brunner, 1984, General Pharmacology.

Assessment of adrenergic beta-blockade in the anesthetized rat at different baseline values.

G. Pöch, F. Brunner, 1984, General pharmacology.

Evaluation and interpretation of dose response experiments with decreased baseline.

G. Pöch, S. Holzmann, H. Bradacs, 1982, Methods and findings in experimental and clinical pharmacology.

Evaluation of the type of overadditive drug interaction under various experimental conditions: differentiation of sequential from functional synergism in dose response studies.

G. Pöch, P. Dittrich, K. Schmidt, 1982, Methods and findings in experimental and clinical pharmacology.

The action of imidazole on the effects of methyl-xanthines and catecholamines on cardiac contraction and phosphorylase activity.

G. Pöch, W. Kukovetz, 1967, The Journal of pharmacology and experimental therapeutics.

Chemical mixture toxicity testing with Vibrio fischeri: combined effects of binary mixtures for ten soft electrophiles.

Gerald Pöch, T. Schultz, G. Pöch, 2006, Ecotoxicology and environmental safety.

Evaluation of an asymmetry parameter for curve-fitting in single-chemical and mixture toxicity assessment.

Nicole Genco, Gerald Pöch, G. Pöch, 2012, Toxicology.

Steroid-saving potency of nonsteroidal antiinflammatory agents--a reevaluation with the new agent CGP 28238 in rat inflammatory models.

G. Pöch, R. Hirschelmann, O. Rickinger, 1991, Agents and actions. Supplements.

Cardiostimulatory effects of oxyfedrine, DMPP and sympathomimetics in relation to their3H-noradrenaline-releasing properties

G. Pöch, W. Kukovetz, 2005, Naunyn-Schmiedebergs Archiv für Pharmakologie.